Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Trichloroethylene risk assessment: a review and commentary.

Jollow DJ, Bruckner JV, McMillan DC, Fisher JW, Hoel DG, Mohr LC.

Crit Rev Toxicol. 2009;39(9):782-97. doi: 10.3109/10408440903222177. Review.

PMID:
19852561
2.

Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol.

Bronley-DeLancey A, McMillan DC, McMillan JM, Jollow DJ, Mohr LC, Hoel DG.

Environ Health Perspect. 2006 Aug;114(8):1237-42.

3.

Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents.

McMillan DC, Powell CL, Bowman ZS, Morrow JD, Jollow DJ.

Toxicol Sci. 2005 Nov;88(1):274-83. Epub 2005 Aug 17.

PMID:
16107547
4.

Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.

Bowman ZS, Jollow DJ, McMillan DC.

J Pharmacol Exp Ther. 2005 Dec;315(3):980-6. Epub 2005 Aug 12.

PMID:
16099929
5.

Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.

Bowman ZS, Morrow JD, Jollow DJ, McMillan DC.

J Pharmacol Exp Ther. 2005 Aug;314(2):838-45. Epub 2005 Apr 19.

PMID:
15840764
6.

Role of oxidant stress in lawsone-induced hemolytic anemia.

McMillan DC, Sarvate SD, Oatis JE Jr, Jollow DJ.

Toxicol Sci. 2004 Dec;82(2):647-55. Epub 2004 Sep 29.

PMID:
15456924
7.

Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates.

Walgren JL, Jollow DJ, McMillan JM.

Toxicology. 2004 May 3;197(3):189-97.

PMID:
15033542
8.

Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.

Bowman ZS, Oatis JE Jr, Whelan JL, Jollow DJ, McMillan DC.

J Pharmacol Exp Ther. 2004 Apr;309(1):79-85. Epub 2004 Jan 14.

PMID:
14724225
10.

Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.

Bolchoz LJ, Gelasco AK, Jollow DJ, McMillan DC.

J Pharmacol Exp Ther. 2002 Dec;303(3):1121-9.

PMID:
12438535
11.
12.

Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell.

Jollow DJ, McMillan DC.

Adv Exp Med Biol. 2001;500:595-605. Review.

PMID:
11765001
13.
14.

Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.

Bolchoz LJ, Budinsky RA, McMillan DC, Jollow DJ.

J Pharmacol Exp Ther. 2001 May;297(2):509-15.

PMID:
11303037
15.

Favism: divicine hemotoxicity in the rat.

McMillan DC, Jollow DJ.

Toxicol Sci. 1999 Oct;51(2):310-6.

PMID:
10543033
16.

Role of lipid peroxidation in dapsone-induced hemolytic anemia.

McMillan DC, Jensen CB, Jollow DJ.

J Pharmacol Exp Ther. 1998 Dec;287(3):868-76.

PMID:
9864266
17.

Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine.

Bradshaw TP, McMillan DC, Crouch RK, Jollow DJ.

Free Radic Biol Med. 1997;22(7):1183-93.

PMID:
9098092
18.

Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine.

Newman WH, Zhang LM, McDonald MH, Jollow DJ, Castresana MR.

Anesth Analg. 1995 Dec;81(6):1229-34.

PMID:
7486109
19.
20.

Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system.

McMillan JM, Jollow DJ.

Res Commun Mol Pathol Pharmacol. 1995 Jun;88(3):327-38.

PMID:
8564388
21.

Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen.

Laskin DL, Gardner CR, Price VF, Jollow DJ.

Hepatology. 1995 Apr;21(4):1045-50.

PMID:
7705777
22.

Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamine.

Bradshaw TP, McMillan DC, Crouch RK, Jollow DJ.

Free Radic Biol Med. 1995 Feb;18(2):279-85.

PMID:
7744312
23.

Dapsone-induced hemolytic anemia.

Jollow DJ, Bradshaw TP, McMillan DC.

Drug Metab Rev. 1995;27(1-2):107-24. Review.

PMID:
7641572
24.

Chemical analysis and hemolytic activity of the fava bean aglycon divicine.

McMillan DC, Schey KL, Meier GP, Jollow DJ.

Chem Res Toxicol. 1993 Jul-Aug;6(4):439-44.

PMID:
8374040
25.

Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity.

Sanders TW Jr, Reinhard MK, Jollow DJ, Hottendorf GH.

Biochem Pharmacol. 1993 Feb 9;45(3):780-2.

PMID:
8442776
26.
27.
28.

The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.

Jensen CB, Jollow DJ.

Toxicol Appl Pharmacol. 1991 Oct;111(1):1-12.

PMID:
1949026
29.

Role of metabolites in propanil-induced hemolytic anemia.

McMillan DC, Bradshaw TP, Hinson JA, Jollow DJ.

Toxicol Appl Pharmacol. 1991 Aug;110(1):70-8.

PMID:
1871773
30.
31.

Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia.

McMillan DC, Bradshaw TP, McMillan JM, Hinson JA, Jollow DJ.

Adv Exp Med Biol. 1991;283:343-5. No abstract available.

PMID:
2069006
32.

Arylamine-induced hemolytic anemia: electron spin resonance spectrometry studies.

Bradshaw TP, McMillan DC, Crouch RK, Jollow DJ.

Adv Exp Med Biol. 1991;283:253-5. No abstract available.

PMID:
1648864
33.

Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide.

Roberts SA, Price VF, Jollow DJ.

Toxicol Appl Pharmacol. 1990 Sep 1;105(2):195-208.

PMID:
2219115
34.

Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.

Peters RH, Ballard K, Oatis JE, Jollow DJ, Stuart RK.

Cancer Chemother Pharmacol. 1990;26(6):397-402.

PMID:
2225310
35.

Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats.

Price VF, Jollow DJ.

Toxicol Appl Pharmacol. 1989 Nov;101(2):356-69.

PMID:
2815088
36.

Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.

Spaethe SM, Jollow DJ.

Biochem Pharmacol. 1989 Jun 15;38(12):2027-38.

PMID:
2742604
37.
38.

Mechanism of decreased acetaminophen glucuronidation in the fasted rat.

Price VF, Jollow DJ.

Biochem Pharmacol. 1988 Mar 15;37(6):1067-75.

PMID:
3128294
39.

Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.

Grossman SJ, Jollow DJ.

J Pharmacol Exp Ther. 1988 Jan;244(1):118-25.

PMID:
3335994
40.

Contribution of aniline metabolites to aniline-induced methemoglobinemia.

Harrison JH Jr, Jollow DJ.

Mol Pharmacol. 1987 Sep;32(3):423-31.

PMID:
3670278
41.

Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis.

Lee WM, Emerson DL, Young WO, Goldschmidt-Clermont PJ, Jollow DJ, Galbraith RM.

Hepatology. 1987 Sep-Oct;7(5):825-30.

PMID:
3115882
42.

Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein).

Young WO, Goldschmidt-Clermont PJ, Emerson DL, Lee WM, Jollow DJ, Galbraith RM.

J Lab Clin Med. 1987 Jul;110(1):83-90.

PMID:
3598340
43.
44.

Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat.

Price VF, Miller MG, Jollow DJ.

Biochem Pharmacol. 1987 Feb 15;36(4):427-33.

PMID:
3827934
45.
46.

Role of aniline metabolites in aniline-induced hemolytic anemia.

Harrison JH Jr, Jollow DJ.

J Pharmacol Exp Ther. 1986 Sep;238(3):1045-54.

PMID:
3746658
47.

Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection.

Miller MG, Jollow DJ.

Toxicol Appl Pharmacol. 1986 Mar 30;83(1):115-25.

PMID:
3952741
48.

Anomalous susceptibility of the fasted hamster to acetaminophen hepatotoxicity.

Miller MG, Price VF, Jollow DJ.

Biochem Pharmacol. 1986 Mar 1;35(5):817-25.

PMID:
3754139
49.

Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity.

Price VF, Jollow DJ.

Biochem Pharmacol. 1986 Feb 15;35(4):687-95.

PMID:
3081010
50.

Hydroxylamines and hemolytic anemia.

Jollow DJ, Grossman SJ, Harrison JH.

Adv Exp Med Biol. 1986;197:573-82. No abstract available.

PMID:
3766282

Supplemental Content

Loading ...
Support Center